Laboratory Findings and Biomarkers in Long COVID: What Do We Know So Far? Insights into Epidemiology, Pathogenesis, Therapeutic Perspectives and Challenges

Long COVID (LC) encompasses a constellation of long-term symptoms experienced by at least 10% of people after the initial SARS-CoV-2 infection, and so far it has affected about 65 million people. The etiology of LC remains unclear; however, many pathophysiological pathways may be involved, including...

Descripción completa

Detalles Bibliográficos
Autores principales: Tsilingiris, Dimitrios, Vallianou, Natalia G., Karampela, Irene, Christodoulatos, Gerasimos Socrates, Papavasileiou, Georgios, Petropoulou, Dimitra, Magkos, Faidon, Dalamaga, Maria
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10341908/
https://www.ncbi.nlm.nih.gov/pubmed/37445634
http://dx.doi.org/10.3390/ijms241310458

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10341908/
https://www.ncbi.nlm.nih.gov/pubmed/37445634
http://dx.doi.org/10.3390/ijms241310458

Ejemplares similares